EndoChoice, Inc.
USPTO PatentsView assignee record - 123 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Endochoice ranks #3,076 of 49,997 tracked US assignees by granted-patent volume, with 123 patents across 17 technology areas.
- #3,076
- of 49,997 US assignees by volume
- Top 21%
- by Innovation Score (46.2/100)
- 16.5
- avg claims per patent
- +16%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3076 · US Corporation #3,076 · 123 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-MID 123 grants
- TOP-DECILE #3,076/49,997
- PHOTO-FINISH Abbott Medical Optics
- CPC-FOCUS A61B · 17 areas
- INNOV-PAR 46.2/100
- CLAIMS-RICH 16.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +16% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Abbott Medical Optics Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Endochoice’s 46.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Endochoice
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- EndoChoice · this assignee
EndoChoice · this assignee
46 score
- Evatec · near
Evatec · near
46 score
- Fieldpiece Instruments · near
Fieldpiece Instruments · near
46 score
- Fingerprint Cards AB · near
Fingerprint Cards AB · near
46 score
- Morpho · near
Morpho · near
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Endochoice's Innovation Score is 46.2/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Endochoice?
Each dot is one of Endochoice’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Endochoice’s own 16.5 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Endochoice's grants concentrate
EndoChoice, Inc. is a focused PatentsView assignee: 17 CPC subclasses with 98.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (15 grants) versus a trough of 3 in 2015. By volume, Endochoice sits between Oceaneering International, Inc. and Headwater Research LLC.
Endochoice's three-year grant acceleration
From 2019–2021 to 2022–2024, EndoChoice, Inc. moved from 42 to 32 grants (0.76x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,951. See the growth leaderboard.
Who files at EndoChoice's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Oceaneering Inter…
Oceaneering International, Inc.
124 patents
- Trudell Medical I…
Trudell Medical International Inc.
124 patents
- Abbott Medical Op…
Abbott Medical Optics Inc.
123 patents
- Endress+Hauser +KG
ENDRESS+HAUSER GMBH+CO.KG
123 patents
- Everi Games
Everi Games Inc.
123 patents
- Futaba Industrial
Futaba Industrial Co., Ltd.
123 patents
- Festo SE & KG
Festo SE & Co. KG
123 patents
- Headwater Research
Headwater Research LLC
123 patents
- Endochoice ◀
EndoChoice, Inc.
123 patents
What this shows EndoChoice holds 123 patents at rank #3,077, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near EndoChoice
By rank, the assignees closest to #3,077 in granted patent volume.
- Oceaneering International, Inc. #3,073 · 124 patents
- Trudell Medical International Inc. #3,074 · 124 patents
- Abbott Medical Optics Inc. #3,075 · 123 patents
- ENDRESS+HAUSER GMBH+CO.KG #3,076 · 123 patents
- Everi Games Inc. #3,078 · 123 patents
- Futaba Industrial Co., Ltd. #3,079 · 123 patents
- Festo SE & Co. KG #3,080 · 123 patents
- Headwater Research LLC #3,081 · 123 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in EndoChoice's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for EndoChoice, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), EndoChoice ranks #151 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (46 here).
Similar claim depth
Nearest assignees by average claims per patent (16.5 here).
Endochoice's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 21% higher than 79% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 2.4% |
| 2016 | 5 | 4.1% |
| 2017 | 13 | 10.6% |
| 2018 | 15 | 12.2% |
| 2019 | 15 | 12.2% |
| 2020 | 13 | 10.6% |
| 2021 | 14 | 11.4% |
| 2022 | 13 | 10.6% |
| 2023 | 8 | 6.5% |
| 2024 | 11 | 8.9% |
| 2025partial year | 13 | 10.6% |
Which technologies does EndoChoice, Inc. patent most?
Top 15 of 17 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
EndoChoice, Inc.'s patent record in context - here's where to go next.
- EndoChoice, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 98.4% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #3,076 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare EndoChoice, Inc. against Oceaneering International, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 46.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.